Evaluation of the individual risk of developing type 2 diabetes mellitus within 10 years by applying the Findrisc scale to users who attend the ambulatory clinic of the Hospital Rural Pedro Vicente Maldonado from October 2017 to December 2017.
Abstract
OBJECTIVE: "To identify the individual risk of developing diabetes mellitus type 2 through the application of the Findrisc Scale in the users who attended the outpatient clinic in the rural hospital Pedro Vicente Maldonado from October 2017 to December 2017"
SPECIFIC OBJECTIVES: To determine the prevalence of the risk of developing type 2 diabetes mellitus by applying the Findrisc scale in the users who attend the outpatient clinic in the Pedro Vicente Maldonado rural hospital. Correlating the effectiveness of screening and its relationship with morbidity and mortality in type 2 diabetes mellitus.
To determine demographic factors related to the risk of developing type 2 diabetes mellitus in the rural area of the northwest of Pichincha-Ecuador.
METHODS: Cross-sectional descriptive study conducted in the town of Pedro Vicente Maldonado located in the Northwest of the Province of Pichincha in a Rural Hospital. Primary information source. We studied 258 people who attended the outpatient clinic of the Pedro Vicente Maldonado hospital from October 2017 to December 2017. The individual risk of developing type 2 diabetes mellitus was identified by applying the Findrisc scale. The analysis was carried out with the EPI INFO 7 program, to obtain a univariate and bivariate analysis, percentages of the quantitative variables were obtained and the search for a relation was made using Fisher's exact test.
RESULTS
The sample size was 258 patients without diagnosis of DM2, of which we found 59% (n = 152) of females; with an average of 49 years of age. From the demographic data we find that 66% (n = 170) of the studied population has more than 6 years of schooling and with a prevalence of 75% (n = 201) of
agricultural activities. When quantifying the Body Mass Index, it was identified that women had a BMI greater than 30 in 11% (n = 17), in relation to 15% (n = 16) of men.Analyzing the behavior of at least 30 minutes of physical activity, it was identified that 62% (n = 160) if they perform daily physical activity, which is in contrast with other studies conducted in urban areas where they do not perform daily physical activity. 43% (n = 113) had a score lower than 7 points on the Findrisc scale, with an individual risk of 1% of presenting diabetes in the next 10 years with a low risk level.
It was also shown that 7% (n = 17) of respondents presented a score between 15 and 20 points with a risk of 33% of presenting diabetes in the next 10 years with a high risk level. Less than 1% (n = 2) presented a score higher than 50 points of presenting diabetes in the next 10 years with a very high level of risk, which is inversely proportional to the worldwide prevalence in the urban area.
CONCLUSION:
The variables studied applying the Scale of Findrisc in the rural area of the northwest of Pichincha are statistically significant in our study as well as in other works carried out in the urban area, however we observe a tendency inversely proportional to other studies that draws our attention to the A score lower than 7 points on the Findrisc scale is presented in the rural area, with an individual risk of 1% of presenting diabetes in the next 10 years with a low level of risk that may be due to the degree of physical activity that the population under study performed daily.
Downloads
References
Pineda MS, Nadal JF, Ellacuria MP, et al. Estadísticas y causas de mortalidad en la diabetes tipo 2. atencion primaria. 2009;27:654-657
De EYE, Obligatoria N, Vigilancia SA, De DPC, Provincias MPOR. Epidemiologia / epi-2. ministerio de salud publica Ecuador. 2007.
Mc Daniel S, Campbell T. Orientación Familiar en Atención Primaria. Barcelona: España: Springer-Verlag Iberica; 1998.
Carmona M, Com MS, Zunzunegui MV, Epidemiol D, Vissandjee B. Deteccion del Riesgo de padecer diabetes mellitus tipo 2 . salud pública de mexico. 2016;49(2).
American Diabetes Association. Diagnosis and classification of diabetes, mellitus. Diabetes Care. 2014;37 Suppl. 1:S81---90.
NICE. Preventing type 2 diabetes: risk identification and interventions for individuals at high risk. NICE public health guidance Issued july 2012 [consultado 20 Ago 2014]. Disponible en: http://www.nice.org.uk/guidance/ph38
Paulweber B, Valensi P, Lindstrom J, Lalic NM, Greaves CJ, McKee M, et al. A European evidence based guideline for the prevention of type 2 diabetes. Horm Metab Res. 2010;42 Suppl. 1:S3---36.
Soriguer F, Goday A, Bosch-Comas A, Bordiú E, Calle-Pascual A, Carmena R, et al. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@betesStudy. Diabetologia. 2012;55:88---93.
Pottie K, Jaramillo A, Lewin G, Dickinson J, Bell N, Brauer P, et al. Canadian Task Force on Preventive Health Care. Recommendations on screening for type 2 diabetes in adults. CMAJ. 2012;184:1687---96.
Gonz A, Avil P. Artículo original Cohesión y adaptabilidad familiar y su relación con la hemoglobina glucosilada de los pacientes diabéticos. revista de especialidades medico quirurgicas. 2011;16(2):82-88.
Victor R, Dilelby S. ESTUDIO DE NECESIDADES PARA LA CREACION DE UN PROGRAMA EDUCATIVO PARA DIABÉTICOS. MEDICO DE FAMILIA. 2004;12(1):23-26.
Pineda MS, Nadal JF, Ellacuria MP, et al. Estadísticas y causas de mortalidad en la diabetes tipo 2. atencion primaria. 2009;27:654-657.
Garcia S. La exploración de la familia, Aspectos medicos, psicológicos y sociales. revista medica del IMSS. 1981;19(2):155-163.
Harris M, Klein R, Welborn T. Onset of NIDDM occurs at least 4-7 years before clinical diagnosis. Diabetes Care. 1992;15(7):815.
María D, López M, Manuel V, et al. Disfuncion familiar y control del paciente diabetico tipo2. revista medica del IMSS. 2004;42.
Pablo A. Guias ALAD de diagnostico,control y tratamiento de la Diabetes Mellitus tipo 2. 2006.
Santacruz VJ. La Familia como unidad de análisis. revista medica del IMSS. 1983;21(4):348-357.
Carmen CTM del. funcionalidad familiar en pacientes diabeticos e hipertensos compensados y descompensados. theoria. 2010;19(1).
Manga UBA, Eps DC, Ariza E, et al. Factores asociados a control metabólico en pacientes diabéticos tipo 2. salud Uninorte Barranquilla. 2005;21:28-40.
Vijan S, Hofer TP, Hayward RA. Estimated Benefits of Glycemic Control in Microvascular Complications in Type 2 Diabetes. Annals of Internal Medicine. 1997;127(9):837-839.
Dis- V, Modified D, Box PO. Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes. The New England Journal of Medicine. 2008:2560-72.
Khaw K-tee, Wareham N, Bingham S, et al. Association of Hemoglobin A 1c with Cardiovascular Disease and Mortality in Adults : The European Prospective Investigation into Cancer in Norfolk. Annals of Internal Medicine. 2004;(12).
Hba E. Glycemic Control and Coronary Heart Disease Risk in Persons With and Without Diabetes. American Medical Association. 2005;165.
Sciences HH, Miller ME, Byington RP, et al. Effects of Intensive Glucose lowering in Type 2 Diabetes. The New England Journal of Medicine. 2008;358(24):2545-2559.
Sereday M, Lapertosa YS. Complicaciones crónicas en personas con diabetes mellitus tipo 2 de reciente diagnostico. endocrinol nutri. 2008;55(1014):64-68.
Menéndez A. Optimización del tratamiento de la diabetes tipo 2 : ajustar el tratamiento al paciente y a la enfermedad. Atención Primaria. 2009;31(2):93,97.
Arroyo J, Badía X, De H, et al. Tratamiento de los pacientes con diabetes mellitus tipo 2 en atención primaria en España. Med Clin (Barc). 2005;125(5):166- 172.
Herrera D. Como se piensan las familias. :1-20.
American Diabetes Association. Standars of medical care in diabetes. diabetes care. 2011;34:1-7.
Kasper DL, Braunwald E, Fauci AS, et al. Principios de Medicina Interna Harrison.
Nathan DM, Kuenen J, Group (ADAG) S. Translating the A1C Assay Into Estimated Average Glucose Values. Diabetes Care. 2008;31(8):1-6.
Copyright (c) 2018 Rural Family Practice

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.